Homocysteine and atherothrombosis

[1]  M. Meydani.  Vitamin E and prevention of heart disease in high-risk patients. , 2009, Nutrition reviews.

[2]  I. Graham,et al.  Plasma homocysteine as a cardiovascular risk factor: causal, consequential, or of no consequence? , 2009, Nutrition reviews.

[3]  Y. Yazaki,et al.  Diet-Induced Hyperhomocysteinemia Exacerbates Neointima Formation in Rat Carotid Arteries After Balloon Injury , 2001, Circulation.

[4]  S. Hulley,et al.  Hormones To Prevent Coronary Disease in Women: When Are Observational Studies Adequate Evidence? , 2000, Annals of Internal Medicine.

[5]  I. Graham,et al.  The role of folic acid in the prevention of cardiovascular disease , 2000, Current opinion in lipidology.

[6]  G. Hankey,et al.  Homocysteine and vascular disease. , 2000, Indian Heart Journal.

[7]  J. Almazán,et al.  The association of dietary folate, B6, and B12 with cardiovascular mortality in Spain: an ecological analysis. , 2000, American journal of public health.

[8]  R. Waugh,et al.  Adaptation and survival of surface-deprived red blood cells in mice. , 2000, American journal of physiology. Cell physiology.

[9]  B. Horne,et al.  Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease , 2000, Circulation.

[10]  K. Rasmussen,et al.  Total homocysteine measurement in clinical practice , 2000, Annals of clinical biochemistry.

[11]  N. Maeda,et al.  Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[12]  R. Virmani,et al.  The good smooth muscle cells in atherosclerosis , 2000, Current atherosclerosis reports.

[13]  J. Loscalzo,et al.  Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. , 2000, The Journal of clinical investigation.

[14]  P. Collinson,et al.  Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. , 2000, Circulation.

[15]  D. Wilcken,et al.  Homocysteine and cardiovascular disease: cause or effect? , 2000, The American journal of clinical nutrition.

[16]  R. Hegele,et al.  Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study. , 2000, American heart journal.

[17]  J. Townend,et al.  Homocysteine and atherothrombosis--mechanisms for injury. , 2000, European heart journal.

[18]  D. Jacobsen,et al.  Hyperhomocysteinemia and oxidative stress: time for a reality check? , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  G. Hankey,et al.  Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. , 2000, Stroke.

[20]  M. Picciano.  Is homocysteine a biomarker for identifying women at risk of complications and adverse pregnancy outcomes? , 2000, The American journal of clinical nutrition.

[21]  R. Glynn,et al.  Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? , 2000, Archives of internal medicine.

[22]  J. Kooner,et al.  Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[23]  E Falk,et al.  Stable versus unstable atherosclerosis: clinical aspects. , 1999, American heart journal.

[24]  J. Ubbink.  Metabolic markers of vitamin nutritional status. , 1999, The American journal of clinical nutrition.

[25]  H. Knapp,et al.  Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. , 1999, Circulation.

[26]  V. Pasceri,et al.  Homocysteine and coronary heart disease: a review of the current evidence. , 1999, Seminars in interventional cardiology : SIIC.

[27]  T. Podor,et al.  Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. , 1999, Blood.

[28]  T. Rabelink,et al.  Future for folates in cardiovascular disease , 1999, European journal of clinical investigation.

[29]  G. Hankey,et al.  Homocysteine and vascular disease , 1999, The Lancet.

[30]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[31]  D. Tribble.  Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and β-Carotene A Statement for Healthcare Professionals From the American Heart Association , 1999 .

[32]  M. Cattaneo.  Hyperhomocysteinemia, Atherosclerosis and Thrombosis , 1999, Thrombosis and Haemostasis.

[33]  R. Krauss,et al.  Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1999, Circulation.

[34]  L. Brudin,et al.  Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. , 1998, Circulation.

[35]  P. Ueland,et al.  Recent data are not in conflict with homocysteine as a cardiovascular risk factor. , 1998, Current opinion in lipidology.

[36]  C. la Vecchia,et al.  Monounsaturated and other types of fat, and the risk of breast cancer , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[37]  J. Ray,et al.  Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. , 1998, Archives of internal medicine.

[38]  Richard A. Johnson.  Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women , 1998 .

[39]  A. Folsom,et al.  Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. , 1998, Circulation.

[40]  L. Kuller,et al.  Homocysteine, vitamins, and cardiovascular disease. , 1998, Circulation.

[41]  J. Witteman,et al.  Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. , 1998, Circulation.

[42]  J. Manson,et al.  Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. , 1998, JAMA.

[43]  Y. Gillerot,et al.  BRCA1 and BRCA2 mutations in Belgian families with a history of breast and/or ovarian cancer , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[44]  S. Vollset,et al.  Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.

[45]  P. Durand,et al.  Acute methionine load‐induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage‐derived tissue factor activity in rats , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  C. la Vecchia,et al.  Fruit and vegetables, and human cancer. , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[47]  A. Majors,et al.  Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[48]  J. Loscalzo,et al.  Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase* , 1997, The Journal of Biological Chemistry.

[49]  W. Willett,et al.  Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. , 1997, The American journal of cardiology.

[50]  J. Powles,et al.  Fruit and vegetables, and cardiovascular disease: a review. , 1997, International journal of epidemiology.

[51]  S. Vollset,et al.  Homocysteine and Cardiovascular Disease , 1996, The Journal of the American Board of Family Medicine.

[52]  J. Loscalzo.  The oxidant stress of hyperhomocyst(e)inemia. , 1996, The Journal of clinical investigation.

[53]  C. Sobey,et al.  Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. , 1996, The Journal of clinical investigation.

[54]  D. Matthias,et al.  Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine. , 1996, Atherosclerosis.

[55]  S. Vollset,et al.  Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. , 1995, JAMA.

[56]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[57]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[58]  N. Maeda,et al.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Celermajer,et al.  Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. , 1993, Journal of the American College of Cardiology.

[61]  G. Rodgers,et al.  Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[62]  J. Sadler,et al.  Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. , 1991, The Journal of clinical investigation.

[63]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[64]  A. Chait,et al.  The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. , 1987, The Journal of biological chemistry.

[65]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[66]  R. Ross,et al.  Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. , 1983, Circulation research.

[67]  R. Havlik,et al.  Cardiovascular risk in heterozygotes for homocystinuria. , 1982, American journal of human genetics.

[68]  D. Wilcken,et al.  Experimental homocysteinemia in pigs: comparison with studies in sixteen homocystinuric patients. , 1982, Metabolism: clinical and experimental.

[69]  R. Havlik,et al.  A study of cardiovascular risk in heterozygotes for homocystinuria. , 1981, American journal of human genetics.

[70]  G. Striker,et al.  Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. , 1980, Thrombosis research.

[71]  K. Krishnaswamy,et al.  Failure to produce atherosclerosis in Macaca radiata on a high-methionine, high-fat, pyridoxine-deficient diet. , 1977, Atherosclerosis.

[72]  R. Ross,et al.  Hyperlipidemia and atherosclerosis. , 1976, Science.

[73]  R. Ross,et al.  Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. , 1976, The Journal of clinical investigation.

[74]  R. Ross,et al.  The pathogenesis of atherosclerosis (second of two parts). , 1976, The New England journal of medicine.

[75]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[76]  D. Wilcken,et al.  The pathogenesis of coronary artery disease. A possible role for methionine metabolism. , 1976, The Journal of clinical investigation.

[77]  G. Gaull,et al.  Arteriosclerosis due to homocyst (e) inemia. Failure to reproduce the model in weanling rabbits. , 1974, The American journal of pathology.

[78]  R. Ross,et al.  Homocystinemia. Vascular injury and arterial thrombosis. , 1974, The New England journal of medicine.

[79]  R. Ross,et al.  Atherosclerosis and the Arterial Smooth Muscle Cell , 1973 .

[80]  K. Mccully.  Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. , 1969, The American journal of pathology.

[81]  D. W. Neill,et al.  Pathological findings in homocystinuria , 1964, Journal of clinical pathology.

[82]  J. Finkelstein,et al.  Homocystinuria: An Enzymatic Defect , 1964, Science.

[83]  R. Cabot,et al.  Case 19471: Marked Cerebral Symptoms Following a Limp of Three Months' Duration , 1933 .

[84]  G. Boers,et al.  Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. , 2000, Seminars in thrombosis and hemostasis.

[85]  T. Rabelink,et al.  Influence of folic acid on postprandial endothelial dysfunction. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[86]  D. Wilcken.  Historical Aspects of the Relationship between Homocysteine and Vascular Disease , 2000 .

[87]  G. Andria,et al.  Vascular Complications of Homocystinuria: Incidence, Clinical Pattern and Treatment , 2000 .

[88]  D. Jacobsen.  Biochemistry and Metabolism , 2000 .

[89]  K. Mccully.  Vascular Pathology of Hyperhomocysteinemia , 2000 .

[90]  A. Khajuria,et al.  Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis. , 2000, Blood.

[91]  R. Wolfe,et al.  Homocysteine metabolism. , 1999, Annual review of nutrition.

[92]  J. Witteman,et al.  Low Circulating Folate and Vitamin B 6 Concentrations Risk Factors for Stroke, Peripheral Vascular Disease, and Coronary Artery Disease , 1998 .

[93]  B. Day.  Fruit and vegetables , 1993 .

[94]  K. Pettigrew,et al.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency. , 1985, American journal of human genetics.

[95]  R. Ross,et al.  Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. , 1973, Science.